Linx S.A. ADR (LINX) Fundamental Analysis & Valuation

NYSE:LINX

7.5
-0.2 (-2.6%)
Last: Jun 25, 2021, 08:04 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This LINX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

LINX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 277 industry peers in the Software industry. Both the profitability and financial health of LINX have multiple concerns. LINX does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. LINX Profitability Analysis

1.1 Basic Checks

  • LINX had negative earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -3.12%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -5.11%
PM (TTM) -8.93%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. LINX Health Analysis

2.1 Basic Checks

  • LINX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

  • LINX has an Altman-Z score of 5.33. This indicates that LINX is financially healthy and has little risk of bankruptcy at the moment.
  • A Debt/Equity ratio of 0.13 indicates that LINX is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 5.33
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

  • LINX has a Current Ratio of 2.14. This indicates that LINX is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio N/A

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. LINX Growth Analysis

3.1 Past

  • LINX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -287.77%.
  • The Revenue for LINX has decreased by -17.40% in the past year. This is quite bad
  • LINX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.79% yearly.
EPS 1Y (TTM)-287.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.45%
Revenue 1Y (TTM)-17.4%
Revenue growth 3Y-4.79%
Revenue growth 5YN/A
Sales Q2Q%-10.42%

3.2 Future

  • The Earnings Per Share is expected to grow by 55.03% on average over the next years. This is a very strong growth
  • LINX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.01% yearly.
EPS Next Y150.95%
EPS Next 2Y76.71%
EPS Next 3Y59.12%
EPS Next 5Y55.03%
Revenue Next Year12.07%
Revenue Next 2Y13.42%
Revenue Next 3Y12.86%
Revenue Next 5Y13.01%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LINX Yearly Revenue VS EstimatesLINX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
LINX Yearly EPS VS EstimatesLINX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. LINX Valuation Analysis

4.1 Price/Earnings Ratio

  • LINX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 78.08, LINX can be considered very expensive at the moment.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.82, LINX is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 78.08
LINX Price Earnings VS Forward Price EarningsLINX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 63.22
LINX Per share dataLINX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • LINX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as LINX's earnings are expected to grow with 59.12% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y76.71%
EPS Next 3Y59.12%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. LINX Dividend Analysis

5.1 Amount

  • LINX has a Yearly Dividend Yield of 1.20%. Purely for dividend investing, there may be better candidates out there.
  • Compared to the average S&P500 Dividend Yield of 1.82, LINX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.2%

5.2 History

  • LINX does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
LINX Yearly Dividends per shareLINX Yearly Dividends per shareYearly Dividends per share 2020 2021 0.02 0.04 0.06 0.08

5.3 Sustainability

DPN/A
EPS Next 2Y76.71%
EPS Next 3Y59.12%

More info and screens

Find the best dividend stocksShow peers with best dividend

LINX Fundamentals: All Metrics, Ratios and Statistics

Linx S.A. ADR

NYSE:LINX (6/25/2021, 8:04:00 PM)

7.5

-0.2 (-2.6%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.42B
Revenue(TTM)165.11M
Net Income(TTM)-14.75M
Analysts60
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.2%
Yearly Dividend0.09
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 78.08
P/S 8.6
P/FCF N/A
P/OCF N/A
P/B 4.79
P/tB N/A
EV/EBITDA 63.22
EPS(TTM)-0.09
EYN/A
EPS(NY)0.1
Fwd EY1.28%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.87
BVpS1.56
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.12%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -5.11%
PM (TTM) -8.93%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.14
Quick Ratio N/A
Altman-Z 5.33
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-287.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.45%
EPS Next Y150.95%
EPS Next 2Y76.71%
EPS Next 3Y59.12%
EPS Next 5Y55.03%
Revenue 1Y (TTM)-17.4%
Revenue growth 3Y-4.79%
Revenue growth 5YN/A
Sales Q2Q%-10.42%
Revenue Next Year12.07%
Revenue Next 2Y13.42%
Revenue Next 3Y12.86%
Revenue Next 5Y13.01%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Linx S.A. ADR / LINX FAQ

What is the ChartMill fundamental rating of Linx S.A. ADR (LINX) stock?

ChartMill assigns a fundamental rating of 4 / 10 to LINX.


What is the valuation status of Linx S.A. ADR (LINX) stock?

ChartMill assigns a valuation rating of 3 / 10 to Linx S.A. ADR (LINX). This can be considered as Overvalued.


Can you provide the profitability details for Linx S.A. ADR?

Linx S.A. ADR (LINX) has a profitability rating of 2 / 10.


What is the financial health of Linx S.A. ADR (LINX) stock?

The financial health rating of Linx S.A. ADR (LINX) is 5 / 10.